The cost-effectiveness of empirical antibiotic treatments for high-risk febrile neutropenic patients: A decision analytic model

PURPOSE: Febrile neutropenia has a significant clinical and economic impact on cancer patients. This study evaluates the cost-effectiveness of different current empiric antibiotic treatments. METHODS: A decision analytic model was constructed to compare the use of cefepime, meropenem, imipenem/cilas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tori, Katerina, Tansarli, Giannoula S., Parente, Diane M., Kalligeros, Markos, Ziakas, Panayiotis D., Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254453/
https://www.ncbi.nlm.nih.gov/pubmed/32443305
http://dx.doi.org/10.1097/MD.0000000000020022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254453/
https://www.ncbi.nlm.nih.gov/pubmed/32443305
http://dx.doi.org/10.1097/MD.0000000000020022

Ejemplares similares